These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10376416)

  • 1. [Comparison of the effects of BI-6, a new asymmetric bipyridine oxime, with HI-6 oxime and obidoxime in combination with atropine on soman and fosdrine toxicity in mice].
    Kassa J
    Ceska Slov Farm; 1999 Jan; 48(1):44-7. PubMed ID: 10376416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
    Kassa J; Bajgar J
    Cas Lek Cesk; 1999 Aug; 138(17):532-5. PubMed ID: 10566233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the effect of selected cholinesterase reactivators combined with atropine on soman and fosdrin toxicity in mice].
    Kassa J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1995; 38(1):63-6. PubMed ID: 9441373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of monopyridinium (2-PAAM, 2-PAEM) and bispyridinium (obidoxime, HI-6) oximes against mevinphos in mice.
    Kassa J; Bielavský J
    Pharmacol Toxicol; 1997 Sep; 81(3):144-6. PubMed ID: 9335072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of parasympatholytics on the therapeutic effectiveness of the oxime HI-6 against organophosphorus compounds (Soman, substance VX, Fosdrin) in mice].
    Kassa J; Vachek J
    Cas Lek Cesk; 1997 Feb; 136(4):124-6. PubMed ID: 9221183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the therapeutic effectiveness of selected cholinesterase reactivators with atropine in acute fosdrine poisoning in mice].
    Kassa J; Bajgar J
    Ceska Slov Farm; 1996 Feb; 45(1):31-4. PubMed ID: 8620316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats.
    Kassa J; Jun D; Kuca K; Bajgar J
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):328-32. PubMed ID: 17910616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats.
    Kassa J; Karasova JZ; Tesarova S; Kuca K; Musilek K
    Toxicol Mech Methods; 2010 Oct; 20(8):445-51. PubMed ID: 20738156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy of new asymmetric bispyridinium oxime BI-6 with other oximes (obidoxime, HI-6) against soman in rats.
    Kassa J
    Hum Exp Toxicol; 1998 Jun; 17(6):331-5. PubMed ID: 9688357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of acetylcholinesterase reactivator dosage on its effectiveness in the treatment of tabun poisoning in mice].
    Kassa J
    Ceska Slov Farm; 2004 Jan; 53(1):31-4. PubMed ID: 15065394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the therapeutic efficacy of some antimuscarinics against soman in vivo.
    Lau WM; Lewis KJ; Dawson RM
    J Appl Toxicol; 1996; 16(5):423-30. PubMed ID: 8889794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of diazepam on the effectiveness of antidote therapy in eliminating the acute lethal effects of soman in mice].
    Kassa J
    Cas Lek Cesk; 2001 Aug; 140(16):497-9. PubMed ID: 11678028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Bajgar J
    Toxicol Mech Methods; 2009 Nov; 19(9):547-51. PubMed ID: 19839724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Kunesova G
    J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.